- Curida AS has marked its 10th anniversary with a new website and unified brand identity, consolidating its three business units.
- The European CDMO now offers integrated services across nasal spray and ophthalmic solutions, biologics and diagnostics, and pharmacy formulations.
Curida AS has celebrated its 10th anniversary by launching a new website and introducing a unified brand identity. The move consolidates the company’s three business units into one integrated platform, strengthening its position as a European contract development and manufacturing organisation (CDMO).
The announcement was marked on 29 August, with local dignitaries, past and present leadership, and the Curida team in attendance. The rebrand reflects Curida’s evolution into a full-spectrum CDMO serving pharmaceutical and diagnostic companies.
Anders Larsson, CEO of Curida, said: “Bringing all parts of the business together under one name and one platform is a natural next step — and an important signal to the market that we are a unified partner, ready to deliver at scale and with speed.”
The integrated business now offers a wide range of services, including nasal spray and ophthalmic solutions, end-to-end CDMO support from early development through to commercial-scale manufacturing, biologics and diagnostic solutions such as monoclonal antibody manufacturing for IVD, and specialised formulations for pharmacies, cosmetics, and nutrition.
The rebrand aligns with broader strategic investments in sites, people, and platforms. Larsson added that Curida’s focus remains on being a responsive and high-quality CDMO partner, committed to supporting better patient outcomes through trusted collaborations.
